The grants, totaling more than $1.7 million in funding for researchers studying canine health, will provide better treatments, more accurate diagnosis, and a deeper understanding of the mechanisms that cause disease in areas such as oncology, cardiology, infectious disease, and musculoskeletal health.
The new grants cover a wide range of health concerns that affect all dogs including the causes of periodontal disease, the most common clinical condition occurring in adult dogs. This study will aid in the development of vaccines and improved treatment methods. Six separate oncology grants were also approved, targeting the number one disease-killer of dogs. Additionally, funding was approved for the study of the prevention of tick-borne diseases and the treatment of urinary incontinence, two common canine health concerns that face dog owners.
To detail the goals and significance of the new research projects, CHF has released a webinar with Dr. Shila Nordone, CHF’s Chief Scientific Officer. Intended for an audience of non-scientists, Dr. Nordone explains how these grants will move canine health forward, eventually helping dogs that come into the veterinary clinic. The webinar can be viewed here.
“By funding grants in diverse program areas CHF is leading the way, improving the quality of life for all dogs, while at the same time supporting research that targets breed-specific issues,” says Nordone.
Since 1995, CHF has invested more than $29 million in canine health research. Funding for CHF grants comes from a variety of sources, including our alliances: the American Kennel Club, Nestlé Purina PetCare, and Pfizer Animal Health. In addition, contributions to help sponsor or fund grants are received from many all-breed, parent, and specialty dog clubs, as well as from individuals all over the world who are committed to canine health research.
To learn more about the CHF grants or to make a donation, click here.